Uzbekistan

Reimbursed Care Access

Uzbekistan maintains strict national controls on narcotics and psychotropic substances: most classical psychedelics (psilocybin, MDMA, DMT, mescaline, etc.) are not authorized for general medical use and are subject to criminal penalties, while ketamine is a controlled psychotropic substance permitted for medical/anesthetic use under regulated supply controls. There is no public evidence of authorized esketamine (Spravato) registration or public reimbursement in Uzbekistan; access to other compounds is limited to approved research or is explicitly prohibited under national narcotics/psychotropic scheduling and the Criminal Code.